Fig. 1From: Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessmentWorkflow of the study. Multi-omics data input for MS-associated risk gene prioritization and validation are labeled in blue. Primary analyses of MS-associated risk gene prioritization and validation are labeled in orange. Analyses on MS-PRGenes and validation gene sets are labeled in redBack to article page